(Q49135523)

English

Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic

scientific article published on 18 November 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic (English)

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

research collaboration

1 reference

based on heuristic

inferred from title

Gabrielle B. Britton

16

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Peter J. Snyder

17

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

22

object named as

Harald Hampel

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

Henrik Zetterberg

6

object named as

Henrik Zetterberg

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

Hugo Vanderstichele

5

object named as

Hugo Vanderstichele

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Michelle M Mielke

2

object named as

Michelle M Mielke

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

7

object named as

Piotr Lewczuk

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Robert A Rissman

3

object named as

Robert A Rissman

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

author name string

Sid E O'Bryant

1

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Simone Lista

4

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Holly Posner

8

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

James Hall

9

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Leigh Johnson

10

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Yiu-Lian Fong

11

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Johan Luthman

12

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Andreas Jeromin

13

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Richard Batrla-Utermann

14

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Alcibiades Villarreal

15

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Kim Henriksen

18

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Paula Grammas

19

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Veer Gupta

20

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Ralph Martins

21

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Biofluid Based Biomarker Professional Interest Area

23

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

publication date

18 November 2016

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Alzheimer's and Dementia

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

13

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

1

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

45-58

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

A blood screening test for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Plasma sphingolipid changes with autopsy-confirmed Lewy Body or Alzheimer's pathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Plasma soluble neuregulin-1 as a diagnostic biomarker for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Translational biomaterials-the journey from the bench to the market-think 'product'.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Early and persistent high level of PS 100β is associated with increased poor neurological outcome in patients with SAH: is there a PS 100β threshold for SAH prognosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Innovative diagnostic tools for early detection of Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Novel plasma biomarker surrogating cerebral amyloid deposition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

The use of biomarkers in human pharmacology (Phase I) studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Plasma proteins predict conversion to dementia from prodromal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Plasma phospholipids identify antecedent memory impairment in older adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Policy: NIH plans to enhance reproducibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Developing novel blood-based biomarkers for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

The future of blood-based biomarkers for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Plasma tau levels in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Association of plasma and cortical amyloid beta is modulated by APOE ε4 status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Blood and plasma-based proteomic biomarker research in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Believe it or not: how much can we rely on published data on potential drug targets?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Biological marker candidates of Alzheimer's disease in blood, plasma, and serum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Drug discovery: new models for industry-academic partnerships

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Insights in the application of research-grade diagnostic kits for biomarker assessments in support of clinical drug development: bioanalysis of circulating concentrations of soluble receptor activator of nuclear factor kappaB ligand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Why most published research findings are false

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

22 May 2018

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

14 August 2018

Exosomes in Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

14 August 2018

Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

14 August 2018

Exosomes as new diagnostic tools in CNS diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

14 August 2018

Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

14 August 2018

Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

14 August 2018

Screening for Alzheimer's disease: inspiration and ideas from breast cancer strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

14 August 2018

Plasma Amyloid Beta-42 Independently Predicts Both Late-Onset Depression and Alzheimer Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

14 August 2018

Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

14 August 2018

Fit-for-purpose method development and validation for successful biomarker measurement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

14 August 2018

Neurotoxicity marker profiles in the CSF are not age-dependent but show variation in children treated for acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5218961

14 August 2018

Disease- and treatment-related elevation of the neurodegenerative marker tau in children with hematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27870940

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of commercial research-grade biomarker assays in drug development: is it time to create 'pharmaceutical-grade' kits?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27870940

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alzheimer disease biomarker testing in cerebrospinal fluid: a method to harmonize assay platforms in the absence of an absolute reference standard

1 reference

https://pubmed.ncbi.nlm.nih.gov/27870940

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant Chemotherapy with or without Zoledronic Acid in Early Breast Cancer--A Randomized Biomarker Pilot Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27870940

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27870940

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27870940

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JALZ.2016.09.014

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 February 2018

http://europepmc.org/abstract/PMC/5218961

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49135523&oldid=2222574153"